Status:
UNKNOWN
Identification of Risk Factors for Acute Coronary Events by OCT After STEMI and NSTEMI in Patients With Residual Non-flow Limiting Lesions
Lead Sponsor:
Radboud University Medical Center
Conditions:
Myocardial Infarction
Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to compare the clinical outcome of Non-ST-elevation myocardial infarction (NSTEMI) and ST-elevation myocardial infarction (STEMI) patients with non-obstructive, non-culp...
Detailed Description
Despite major advances in the treatment of acute coronary syndromes a large proportion of patients is still at risk for new coronary events after experiencing an acute coronary syndrome (ACS). Detecti...
Eligibility Criteria
Inclusion
- Informed consent must be obtained.
- Patients with STEMI or NSTEMI and residual, non-culprit CAD, with the possibility of plaque vulnerability.
- Residual plaque(s) is(are) non-obstructive (FFR≥0.80).
Exclusion
- Refusal or inability to provide informed consent.
- \< 18 years of age
- Hemodynamic instability, respiratory failure, Kilip class ≥ 3.
- Previous Coronary Artery Bypass Grafting (CABG).
- Indication for revascularization by CABG.
- Anatomy or lesions unsuitable for OCT catheter crossing or imaging (aorta-ostial lesions, small diameter segment, severe calcifications, lesion is too distal for OCT catheter)
- Pregnancy.
- Estimated life expectancy \< 3 year
Key Trial Info
Start Date :
December 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 14 2025
Estimated Enrollment :
438 Patients enrolled
Trial Details
Trial ID
NCT03857971
Start Date
December 14 2018
End Date
June 14 2025
Last Update
September 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, South Holland, Netherlands, 6500HB